Metabolic Profile Variations along the Differentiation of Human-Induced Pluripotent Stem Cells to Dopaminergic Neurons.

dopaminergic neurons iPSCs mass spectrometry metabolism neuronal differentiation

Journal

Biomedicines
ISSN: 2227-9059
Titre abrégé: Biomedicines
Pays: Switzerland
ID NLM: 101691304

Informations de publication

Date de publication:
24 Aug 2022
Historique:
received: 27 07 2022
revised: 17 08 2022
accepted: 20 08 2022
entrez: 23 9 2022
pubmed: 24 9 2022
medline: 24 9 2022
Statut: epublish

Résumé

In recent years, the availability of induced pluripotent stem cell-based neuronal models has opened new perspectives on the study and therapy of neurological diseases such as Parkinson's disease. In particular, P. Zhang set up a protocol to efficiently generate dopaminergic neurons from induced pluripotent stem cells. Although the differentiation process of these cells has been widely investigated, there is scant information related to the variation in metabolic features during the differentiation process of pluripotent stem cells to mature dopaminergic neurons. For this reason, we analysed the metabolic profile of induced pluripotent stem cells, neuronal precursors and mature neurons by liquid chromatography-tandem mass spectrometry. We found that induced pluripotent stem cells primarily rely on fatty acid beta-oxidation as a fuel source. Upon progression to neuronal progenitors, it was observed that cells began to shut down fatty acid β-oxidation and preferentially catabolised glucose, which is the principal source of energy in fully differentiated neurons. Interestingly, in neuronal precursors, we observed an increase in amino acids that are likely the result of increased uptake or synthesis, while in mature dopaminergic neurons, we also observed an augmented content of those amino acids needed for dopamine synthesis. In summary, our study highlights a metabolic rewiring occurring during the differentiation stages of dopaminergic neurons.

Identifiants

pubmed: 36140170
pii: biomedicines10092069
doi: 10.3390/biomedicines10092069
pmc: PMC9495704
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Fondazione Cariplo
ID : 2015
Organisme : Ministry of Education, Universities and Research
ID : PRIN-2017
Organisme : Mizutani Foundation for Glycoscience
ID : 2021
Organisme : Ministry of Education, Universities and Research
ID : Progetto Eccellenza (2018-2022)

Références

Nature. 2007 Jul 19;448(7151):313-7
pubmed: 17554338
Sci Rep. 2016 Feb 04;6:20270
pubmed: 26842779
Front Cell Dev Biol. 2015 Feb 02;3:2
pubmed: 25699255
Eur J Neurosci. 1992;4(12):1376-1386
pubmed: 12106401
Cell Stem Cell. 2011 Mar 4;8(3):267-80
pubmed: 21362567
J Vis Exp. 2014 Sep 15;(91):51737
pubmed: 25285746
Cell Tissue Res. 2018 Jan;371(1):143-151
pubmed: 29079884
PLoS One. 2011;6(11):e26159
pubmed: 22110584
Acta Neuropathol. 2008 Apr;115(4):385-98
pubmed: 18273623
Curr Protoc Bioinformatics. 2019 Dec;68(1):e86
pubmed: 31756036
Science. 2007 Dec 21;318(5858):1917-20
pubmed: 18029452
Nat Biotechnol. 2018 Apr 5;36(4):316-320
pubmed: 29621222
Nature. 2009 Jan 15;457(7227):277-80
pubmed: 19098894
Science. 2008 Aug 29;321(5893):1218-21
pubmed: 18669821
Eur Neurol. 1997;38 Suppl 2:2-7
pubmed: 9387796
J Neuropathol Exp Neurol. 1996 Mar;55(3):259-72
pubmed: 8786384
Nat Protoc. 2007;2(12):3081-9
pubmed: 18079707
Mov Disord. 2017 Sep;32(9):1264-1310
pubmed: 28887905
Brain Res Dev Brain Res. 1995 Nov 21;89(2):187-201
pubmed: 8612323
Lancet. 2004 May 29;363(9423):1783-93
pubmed: 15172778
Nature. 2011 Nov 06;480(7378):547-51
pubmed: 22056989
Front Oncol. 2018 Apr 23;8:126
pubmed: 29740540
Inflamm Regen. 2020 May 12;40:8
pubmed: 32426078
Ann Neurol. 2008 Dec;64 Suppl 2:S101-10
pubmed: 19127580
Cell. 2007 Nov 30;131(5):861-72
pubmed: 18035408
Methods Mol Biol. 2013;964:295-308
pubmed: 23296790
Cell Metab. 2017 Jan 10;25(1):27-42
pubmed: 27641100
Bioessays. 2002 Apr;24(4):308-18
pubmed: 11948617

Auteurs

Emma Veronica Carsana (EV)

Department of Medical Biotechnology and Translational Medicine, University of Milan, 20054 Milan, Italy.

Matteo Audano (M)

Department of Pharmacological and Biomolecular Sciences, University of Milan, 20122 Milan, Italy.

Silvia Breviario (S)

Department of Medical Biotechnology and Translational Medicine, University of Milan, 20054 Milan, Italy.

Silvia Pedretti (S)

Department of Pharmacological and Biomolecular Sciences, University of Milan, 20122 Milan, Italy.

Massimo Aureli (M)

Department of Medical Biotechnology and Translational Medicine, University of Milan, 20054 Milan, Italy.

Giulia Lunghi (G)

Department of Medical Biotechnology and Translational Medicine, University of Milan, 20054 Milan, Italy.

Nico Mitro (N)

Department of Pharmacological and Biomolecular Sciences, University of Milan, 20122 Milan, Italy.

Classifications MeSH